130 Attend NHIA Talk Infusion Webinar on Compliance and Risk Considerations for Compounding Pharmacies

Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities

FDA cited Akorn’s New Jersey plant even as drugmaker fought Fresenius in court over abandoned buyout